Purple Biotech Files 6-K with Warrant and Placement Agent Forms
Ticker: PPBT · Form: 6-K · Filed: Jul 2, 2024 · CIK: 1614744
Sentiment: neutral
Topics: financing, warrants, filing
TL;DR
Purple Biotech files 6-K detailing warrant repricing and placement agent forms, signaling potential equity moves.
AI Summary
Purple Biotech Ltd. filed a Form 6-K on July 2, 2024, reporting on events for the month of July 2024. The filing includes several exhibits related to warrant agreements, specifically a Form of Warrant Reprice and Reload Letter (Exhibit 1.1 and 1.2), and forms for Series A-1 and A-2 Warrants (Exhibit 1.3 and 1.4). It also lists a Form of Placement Agent agreement as Exhibit 1.5.
Why It Matters
This filing indicates potential future equity financing or adjustments to existing warrants, which could impact the company's capital structure and shareholder dilution.
Risk Assessment
Risk Level: medium — The filing relates to financial instruments (warrants) and potential agent agreements, which can introduce financial and strategic risks.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer of the 6-K report
- Kitov Pharma Ltd. (company) — Former company name
- Kitov Pharmaceuticals Holdings Ltd. (company) — Former company name
FAQ
What is the purpose of the Warrant Reprice and Reload Letters?
The filing does not explicitly state the purpose, but these forms (Exhibit 1.1 and 1.2) typically relate to adjustments in the exercise price or terms of outstanding warrants.
What are the Series A-1 and Series A-2 Warrants?
These are specific forms of warrants (Exhibit 1.3 and 1.4) that Purple Biotech Ltd. is referencing in this filing, likely related to past or planned financing rounds.
What is the significance of the Form of Placement Agent agreement?
This form (Exhibit 1.5) suggests that Purple Biotech Ltd. may be engaging or has engaged a placement agent to assist in raising capital through the sale of securities.
When was Purple Biotech Ltd. formerly known as Kitov Pharma Ltd.?
The date of the name change from Kitov Pharma Ltd. to Purple Biotech Ltd. was January 25, 2018.
Where is Purple Biotech Ltd. located?
Purple Biotech Ltd.'s principal executive offices are located at 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel.
Filing Stats: 593 words · 2 min read · ~2 pages · Grade level 17.8 · Accepted 2024-07-02 16:05:14
Filing Documents
- ea0208869-6k_purplebio.htm (6-K) — 15KB
- ea020886901ex1-1_purplebio.htm (EX-1.1) — 74KB
- ea020886901ex1-2_purplebio.htm (EX-1.2) — 71KB
- ea020886901ex1-3_purplebio.htm (EX-1.3) — 108KB
- ea020886901ex1-4_purplebio.htm (EX-1.4) — 103KB
- ea020886901ex1-5_purplebio.htm (EX-1.5) — 106KB
- 0001213900-24-058591.txt ( ) — 478KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. July 2, 2024 PURPLE BIOTECH LTD. By: /s/ Lior Fhima Lior Fhima Chief Financial Officer 2